Uterine Fibroids Treatment Market Forecast To 2024 Made Available By Top Research Firm
The rising occurrence of uterine fibroids among women is the primary stimulant of the growth of the U.S. market for uterine fibroids treatment. The Society of Interventional Radiology states that around 30% to 40% of women aged 35 and above suffer from uterine fibroids. Moreover, the advent of minimally invasive and effective alternatives to open surgeries is working in favor of the market. The presence of favorable reimbursement policies is also encouraging patients to undergo uterine fibroids treatment. Medicare & Medicaid services – a national social insurance program in the U.S. – covers reimbursement policies and payments for ambulatory surgical centers and hospitals.
View Report: https://www.transparencymarketresearch.com/us-uterine-fibroid-treatment-market.html
Furthermore, technological advancements and frequent product innovations coupled with an increase in regulatory approvals of novel products are stoking the growth of the market. However, the presence of substitutes such as drug therapy to uterine fibroid treatment procedures is hampering the growth of the market. Moreover, stringent regulations pertaining to treatment devices delay their launch, which in turn adversely affects the growth of the market. With all these factors put together, the U.S. market for uterine fibroid treatment is poised to reach a valuation of US$273.6 mn by the end of 2024 from US$217.6 mn in 2016, rising at a CAGR of 2.9% between 2016 and 2024.
Hysterectomy to Remain Most Preferred Uterine Fibroid Treatment Procedure through 2024
Based on type of procedure, the hysterectomy segment will continue to represent the lion’s share in the U.S. market for uterine fibroids treatment until 2024. The segment can be further classified into laparoscopic hysterectomy, abdominal hysterectomy, robotic hysterectomy, vaginal hysterectomy, and hysteroscopic morcellation. Hysterectomy is the commonly recommended procedure by doctors to women who have large fibroid size and have completed their fertility. According to the American Congress of Obstetricians and Gynecologists, every year nearly 600,000 hysterectomy procedures are performed. However, the segment is expected to register sluggish growth owing to the injury to healthy tissue and risk of having benign neoplasms after a hysterectomy procedure.
Request a Brochure of Uterine Fibroids Treatment Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16775
The demand for radiofrequency ablation, on the other hand, is likely to increase at a significant pace over the coming years. The increasing demand for minimally invasive procedures is one of the primary factors contributing to the growth of the segment. The fast recovery associated with this procedure coupled with the low complications and risk factor is translating into the greater adoption of this procedure. The segment is estimated to exhibit a CAGR of 7.4% during the forecast period.
Highly Developed Infrastructure Ensures Strong Demand across Hospitals
On the basis of end user, the U.S. uterine fibroids treatment market is divided into hospitals and ambulatory surgical centers. The demand for uterine fibroids treatment is higher in hospitals, owing to the fact that they are highly developed to handle complicated matters and emergencies related to uterine fibroids. Large hospitals are increasingly focusing towards training interventional radiologists and gynecologists for application of radiofrequency ablation and robotic minimally invasive procedure, which is likely to provide a significant boost to the growth of the segment. Owing to these factors, the segment is expected to post a CAGR of 3.1% during the forecast period.
The ambulatory surgical centers segment is anticipated to rise at a sluggish pace during the same period, owing to the high cost of procedures in these centers along with the lack of favorable reimbursement scenario.
Some of the prominent players in the U.S. uterine fibroids market are Richard Wolf Medical Instruments, Blue Endo, Halt Medical Inc., LiNA Medical USA, Cooper Surgical, Merit Medical Systems, Karl Storz, Olympus Corporation, Richard Wolf GmbH, and Boston Scientific Corporation.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uterine Fibroids Treatment Market Forecast To 2024 Made Available By Top Research Firm here
News-ID: 1848495 • Views: 144
More Releases from Transparency Market Research
Pad Printing Machine Market - Provides Veritable Information on Size, Growth Tre …
Pad Printing Machine Market: An Overview Need for an effective printing machine which can lay down simple one colored image or complex multicolor graphics to about every object helped in the introduction of pad printing machine. It is used to transfer a 2-D image via a silicon padon to a 3-D object on any type of surface like flat, spherical, irregular or cylindrical. Pad printing machine also prints photos or other
Varnished Cambric Tape Market - Company Strategy, Product Portfolio and Recent D …
Varnished cambric tape Market: An Overview The growth of renewable power generation will be an elementary factor to push the demand for the electrical wires and cables market across the globe, the countries are focusing more on power generation through renewable resources available in comparison with conventional (coal, thermal, etc.) power generation methodology, the transmission and distribution of electrical infrastructure is not only required to be completely developed in developed economies
Hip Flask Market | Reporting and Evaluation of Recent Industry Developments & Bu …
Hip Flask Market: An Overview Similar to the mobile, the hip flask started to appear in the form it was recognized today in the 18th century, the primarily hip flask was mainly used by the well-born people of high social class especially in the past. Initially, the hip flask was made of malleable metal alloy (Pewter), silver, gold, copper, and glass, but nowadays hip flask is also available in stainless steel
Cargo Pit Tape Market - Research Forecast, Revenue Opportunities And Sales Volum …
Cargo Pit Tape Market: An Overview The most important element in packaging is quality of adhesive to be used in packaged items to maintain the same quality throughout the supply chain till the time it reaches the destination safely. There are many types of packaging tapes available in the market with different applications. Polypropylene Tape: it’s economical, durable, and reliable and resistant to breaking or tearing during the shipping. Printed Fragile Tape: It
More Releases for Uterine
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Uterine Fibroids Treatment Market : Hysterectomy to Remain Most Preferred Uterin …
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape. Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers
Uterine Leiomyoma (Uterine Fibroids) Market: Global Industry Size, Share, Growth …
Latest industry research report on: Global Uterine Leiomyoma Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. DelveInsight's,Uterine Leiomyoma (Uterine Fibroids)-Global API Manufacturers,Marketed and Phase III Drugs Landscape,2018" report provides comprehensive insights about marketed and Phase III products for Uterine Leiomyoma (Uterine Fibroids) . The report includes information of marketed products including their product description,patent details,forecasted sales till 2020 & API manufacturer details by country. Global API
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2017”. Uterine fibroids are benign tumors that originate in the uterus (womb). Although they are composed of the same smooth muscle fibers as the uterine wall (myometrium), they are much denser than normal myometrium. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246573 Uterine fibroids are usually round. The most common
Uterine Cancer Therapeutics market report by 2021
According to the report “Global Uterine Cancer Therapeutics Market", published by Market Data Forecast, the global market is projected to reach USD 22,686.3 million by 2021, at a CAGR of 5.45 % from 2016 to 2021. For full report refer to : http://www.marketdataforecast.com/market-reports/global-uterine-cancer-therapeutics-market-1489/ Uterine cancer is one of most commonly prevailing malignant tumours that starts in the cells of the uterus and spreads to other parts of the body. Uterine